[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336811-105":59,"doc-detail-336811-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncomir-181a-promotes-carcinogenesis-by-repressing-the-extracellular-matrix-proteoglycan-decorin-in-hepatocellular-carcinoma","OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma","","Proteoglycans are key components of the tumor microenvironment, and miRNA-driven control of the proteoglycan decorin (DCN) has emerged as a potential cancer target. This study investigates how miR-181a influences liver cancer by regulating extracellular matrix DCN and downstream oncogenic and tumor-suppressor pathways. Results show DCN is reduced in cirrhotic and HCC tissues, while miR-181a is increased in HCC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncomir-181a-promotes-carcinogenesis-by-repressing-the-extracellular-matrix-proteoglycan-decorin-in-hepatocellular-carcinoma/336811/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncomir-181a-promotes-carcinogenesis-by-repressing-the-extracellular-matrix-proteoglycan-decorin-in-hepatocellular-carcinoma/336811.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main aim regarding miR-181a?","Question",{"text":112,"@type":113},"To determine the impact of miR-181a in liver cancer and its regulatory role on extracellular matrix proteoglycan DCN and downstream oncogenic and tumor-suppressor genes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do DCN and miR-181a expression levels differ between tissues?",{"text":117,"@type":113},"DCN is under-expressed in cirrhotic and HCC tissues compared with healthy liver tissues, while miR-181a is over-expressed in HCC tissues compared with healthy liver tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects did DCN reduction and miR-181a overexpression show?",{"text":121,"@type":113},"Both miR-181a and DCN siRNAs enhanced cellular viability, proliferation, and clonogenicity, increased Myc and E2F signaling, and decreased p53 and Rb signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336811,1790144114,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Assal etal. BMCGastroenterology (2024) 24:337 [https://doi.org/10.1186/s12876-024-03413-6](https://doi.org/10.1186/s12876-024-03413-6)  \nBMC Gastroenterology  \nRESEARCH Open Access  \nOncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma  \nReem Amr Assal 1,2, Rowan Bahaa El-din Abd El-bary3, Rana A. Youness4, Mohamed Mamdouh Abdelrahman5, Hala Zahran6, Karim Adel Hosny7, Gamal Esmat8, Kai Breuhahn9, Nada El-Ekiaby3, Injie Omar Fawzy3 and Ahmed Ihab Abdelaziz3*  \nAbstract  \nBackground Proteoglycans are important tumor microenvironment extracellular matrix components. The regulation of key proteoglycans, such as decorin (DCN), by miRNAs has drawn attention since they have surfaced as novel therapeutic targets in cancer. Accordingly, this study aimed at identifying the impact of miR-181a in liver cancer and its regulatory role on the extracellular matrix proteoglycan, DCN, and hence on downstream oncogenes and tumor suppressor genes.  \nResults DCN was under-expressed in 22 cirrhotic and HCC liver tissues compared to that in 11 healthy tissues of liver transplantation donors. Conversely, miR-181a was over-expressed in HCC liver tissues compared to that in healthy liver tissues. In silico analysis predicted that DCN 3’UTR harbors two high-score oncomiR-181a binding regions. This was validated by pmiRGLO luciferase reporter assay. Ectopic miR-181a expression into HuH-7 cells repressed the transcript and protein levels of DCN as assessed fluorometrically and by western blotting. DCN siRNAs showed similar results to miR-181a, where they both enhanced the cellular viability, proliferation, and clonogenicity. They also increased Myc and E2F and decreased p53 and Rb signaling as assessed using reporter vectors harboring p53, Rb, Myc, and E2F response elements. Our findings demonstrated that miR-181a directly downregulated the expression of its direct downstream target DCN, which in turn affected downstream targets related to cellular proliferation and apoptosis. Conclusion To our knowledge, this is the first study to unveil the direct targeting of DCN by oncomiR-181a. We also highlighted that miR-181a affects targets related to cellular proliferation in HCC which may be partly mediated through inhibition of DCN transcription. Thus, miR-181a could be a promising biomarker for the early detection and monitoring of liver cancer progression. This would pave the way for the future targeting of the oncomiR-181a as a therapeutic approach in liver cancer, where miR-181a-based therapy approach could be potentially combined with chemotherapy and immunotherapy for the management of liver cancer.  \n*Correspondence: Ahmed Ihab Abdelaziz [aihab@ngu.edu.eg](aihab@ngu.edu.eg)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nAssal et al. BMC Gastroenterology (2024) 24:337 Page 2 of 14  ","cbCaino17YOCyWOc","https://ap.wps.com/l/cbCaino17YOCyWOc","pdf",1740760,14,"English","# Abstract\n# Background\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What was the study’s main aim regarding miR-181a?\",\"answer\":\"To determine the impact of miR-181a in liver cancer and its regulatory role on extracellular matrix proteoglycan DCN and downstream oncogenic and tumor-suppressor genes.\"},{\"question\":\"How do DCN and miR-181a expression levels differ between tissues?\",\"answer\":\"DCN is under-expressed in cirrhotic and HCC tissues compared with healthy liver tissues, while miR-181a is over-expressed in HCC tissues compared with healthy liver tissues.\"},{\"question\":\"What functional effects did DCN reduction and miR-181a overexpression show?\",\"answer\":\"Both miR-181a and DCN siRNAs enhanced cellular viability, proliferation, and clonogenicity, increased Myc and E2F signaling, and decreased p53 and Rb signaling.\"}]","OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma | PDF",1790016702,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c465c34f4e75a6b24c6a11020a90fec.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/228ab56f9f856995ab6253c6c796806d.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d322abf02b3b5393e4ece60a293b357.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26a560ebb9082dc6402e4575f0240bd9.webp",980,1306]